Nhlbi catalyze program - preclinical services component
Active Awarded Last action
- Contract number
- 75N92022A00005
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 6 $36,842,054 obligated
Award facts
- Combined order value
- $36,842,054 Current and potential, with all options
- Last date to order 81% complete
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Heart Lung and Blood Institute established a Blanket Purchase Agreement with Research Triangle Institute (RTI International) on September 30, 2022, against the GSA Multiple Award Schedule, for preclinical research and development services supporting the NHLBI CATALYZE program, with an ultimate completion date of September 29, 2027.
Place of performance spans Durham, North Carolina and Kensington, Maryland. The BPA carries a zero ceiling value in the parent vehicle record; however, five active BPA calls have been issued totaling $26.8 million across the performance period. The most recent call, issued September 29, 2025, is a $9.999 million time-and-materials order for CATALYZE Preclinical Services Year 4 projects with performance through September 28, 2026, based in Kensington. An August 23, 2024 call valued at $8.628 million for Year 3 projects includes subcontractors Cambrex (Avista Pharma Solutions), Lovelace Biomedical Research Institute, Lonza Bend, Frontage Laboratories, Eurofins Advinus, and Concord Biosciences for preclinical testing and research materials. A September 25, 2023 call for $3.234 million covered Year 2 projects with Charles River Laboratories, Lonza Sales AG, and Allele Biotechnology as major subs. An initial $944,461 labor-hours call from September 30, 2022 (preclinical services projects) and a $4.035 million administrative services call (also September 30, 2022, through September 29, 2027) round out the documented activity. Calls are issued on time-and-materials or labor-hours pricing structures.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Subawards
Show all 40
Quick answers
Who was awarded contract 75N92022A00005?
75N92022A00005 was awarded to Research Triangle Institute by National Heart Lung and Blood Institute (National Institutes of Health) on September 30, 2022.
How much is contract 75N92022A00005 worth?
Orders under 75N92022A00005 have obligated $36,842,054.
How many orders have been placed under contract 75N92022A00005?
6 orders have been placed under 75N92022A00005, the latest on September 30, 2026.
Who can order from contract 75N92022A00005?
75N92022A00005 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75N92022A00005 under another contract?
Yes. 75N92022A00005 is a blanket purchase agreement under GS00F354CA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N92022A00005 competed?
The extent of competition for 75N92022A00005 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV